We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Emerging techniques on how to prevent or minimise the environmental impacts of industrial hydrogen production from methane or refinery fuel gas with carbon capture for storage.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to write up and share your findings
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
Guidance to help organisations choose a monitoring approach for stack emissions to air that meets Environment Agency and MCERTS requirements (formerly part of M2).
Information on enhancing communications resilience and how we work with telecommunication service providers to manage the risk of disruption to public networks.
Information from the National Health Service on conditions, treatments, local services and healthy living
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Government funding for innovation in smart energy systems and technologies
Description of UKHSA adult surveillance programmes for COVID-19.
Information about local services that have been disrupted by severe weather conditions
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Organisational definitions of terms concerned with risk and risk-related matters.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.